Article
MAO-B and COMT Genetic Variations Associated With Levodopa Treatment Response in Patients With Parkinson's Disease.
Journal of clinical pharmacology - 1 Jul 2018
Sampaio Tiago Furtado, Dos Santos Erinaldo Ubirajara Damasceno, de Lima Gessica Dayane Cordeiro, Dos Anjos Rute Salgues Gueiros, da Silva Ronaldo Celerino, Asano Amdore Guescel C, Asano Nadja Maria Jorge, Crovella Sergio, de Souza Paulo Roberto Eleutério
Abstract excerpt
The most commonly used Parkinson's disease (PD) treatment is the replacement of dopamine by its levodopa precursor (l-dopa). Monoamine oxidase-B (MAO-B) and catechol-o-methyl transferase (COMT) are enzymes involved in the metabolism and regulation of dopamine availability. In our study we investigated the possible relation among selected single-nucleotide polymorphisms (SNPs) in the MAO-B (rs1799836) and COMT...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
